Trial Profile
Phase 1 study of KBP-7026 for asthma/COPD
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 10 Jan 2018
Price :
$35
*
At a glance
- Drugs KBP-7026 (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Adverse reactions
- 10 Jan 2018 New trial record